Tower Research Capital »

Athira Pharma shares owned by Tower Research Capital

Quarter-by-quarter ownership of Athira Pharma shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6k 638 4.14

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma